V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010463 | 270006143 | 1.7 | 75.3 | Curative (C) | 2017-05-13 | 2017-05-13 | Cetuximab 14 day | N | N | 270025272 | CETUXIMAB + IRINOTECAN + MDG |
| 270010464 | 270006144 | 1.65 | 83.4 | Adjuvant (A) | 2017-12-14 | 2017-12-19 | Cisplatin + Fluorouracil + RT 5day | N | N | 270025294 | CISPLATIN + VINORELBINE |
| 270010465 | 270006145 | 1.76 | 57 | Curative (C) | 2017-11-29 | 2017-12-19 | Carboplatin AUC 2 - 5 | N | N | 270025305 | GEMCITABINE + NAB-PACLITAXEL |
| 270010466 | 270006145 | 1.78 | 91.3 | Palliative (P) | 2013-10-04 | 2013-10-09 | CAPECITABINE + CARBOPLATIN | N | N | 270025305 | CARBOPLATIN |
| 270010467 | 270006146 | null | 74.8 | Palliative (P) | null | 2015-10-27 | CARBOPLATIN + FLUOROURACIL | N | N | 270025309 | GEMCARBO |
| 270010468 | 270006147 | 1.59 | 63.8 | Adjuvant (A) | 2014-10-02 | 2014-10-10 | Carboplatin AUC 6 - 10 | N | N | 270025319 | CETUXIMAB + RT |
| 270010469 | 270006148 | 1.73 | 82 | Curative (C) | 2015-01-31 | 2015-02-05 | Rituximab | N | Y | 270025333 | BENDAMUSTINE + RITUXIMAB |
| 270010470 | 270006148 | null | 93 | null | 2013-12-04 | 2013-12-11 | CARBOPLATIN | 2 | N | 270025333 | CARBOPLATIN |
| 270010471 | 270006148 | 1.62 | null | Curative (C) | 2013-11-07 | 2014-02-06 | Cetuximab + Radiotherapy Load | N | N | 270025333 | CARBOPLATIN + PEMETREXED |
| 270010472 | 270006149 | null | null | Not known (9) | 2017-04-04 | 2017-04-28 | CARBOPLATIN + RT | null | N | 270025354 | CISPLATIN + VINORELBINE |
| 270010473 | 270006149 | 1.69 | null | null | null | 2014-10-22 | Carboplatin AUC 2 - 5 | N | N | 270025354 | CARBOPLATIN + PEMETREXED |
| 270010474 | 270006150 | 1.65 | 95 | Neo-adjuvant (N) | 2016-07-10 | 2016-08-12 | Cetuximab + Radiotherapy Load | N | N | 270025368 | SCOT TRIAL |
| 270010475 | 270006151 | 1.69 | null | Neo-adjuvant (N) | 2013-03-25 | 2013-05-03 | CARBOPLATIN + RT | 99 | null | 270025379 | SCOT TRIAL |
| 270010476 | 270006152 | null | 104.5 | Curative (C) | 2012-05-04 | 2013-05-01 | Bevacizumab 10mg/kg | N | N | 270025395 | CETUXIMAB + RT |
| 270010477 | 270006153 | 1.58 | 91.5 | null | 2014-05-13 | 2014-05-18 | Carboplatin + Pemetrexed | N | N | 270025396 | CARBOPLATIN + RT |
| 270010478 | 270006154 | 1.6 | 55.3 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-29 | CARBOPLATIN + FLUOROURACIL | 02 | N | 270025413 | CETUXIMAB + CISPLATIN + FU |
| 270010479 | 270013008 | 1.64 | 108.4 | Palliative (P) | 2014-10-29 | 2014-11-14 | Cetuximab + Radiotherapy Maint | N | N | 270025418 | ENZALUTAMIDE |
| 270010480 | 270016119 | 1.76 | 68.4 | Palliative (P) | 2014-04-16 | 2014-04-16 | ETOPOSIDE + RITUXIMAB | 02 | N | 270025433 | GDP |
| 270010481 | 270017892 | 1.49 | 57.5 | null | 2016-06-19 | 2016-06-20 | GEMCITABINE | N | N | 270025437 | VINBLASTINE |
| 270010482 | 270018914 | null | 47 | Not known (9) | null | 2014-04-08 | TCF | null | null | 270025443 | FLUOROURACIL + RT |
| 270010483 | 270019490 | 1.71 | 93 | Adjuvant (A) | 2018-02-27 | 2018-03-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270025454 | CETUXIMAB + RT |
| 270010484 | 270006155 | 1.59 | 55 | Curative (C) | 2014-05-13 | 2015-05-23 | Docetaxel | N | N | 270025470 | ARISTOTLE TRIAL |
| 270010485 | 270006156 | null | 89 | Adjuvant (A) | null | 2014-02-20 | CARBOPLATIN + RT | null | null | 270025474 | FLUOROURACIL + RT |
| 270010486 | 270006157 | 1.64 | 75.1 | Curative (C) | 2014-05-05 | 2014-05-07 | CHOP | N | N | 270025475 | RITUXIMAB |
| 270010487 | 270013009 | null | null | Curative (C) | 2017-10-07 | 2017-10-17 | Cetuximab 14 day | N | N | 270025482 | CETUXIMAB |
| 270010488 | 270006158 | null | null | Palliative (P) | 2015-08-01 | 2015-08-02 | GEMCITABINE | N | null | 270025484 | CETUXIMAB + RT |
| 270010489 | 270006159 | 1.79 | 67.2 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-29 | Cisplatin + Etoposide po&iv 3 day | N | N | 270025491 | CETUXIMAB |
| 270010490 | 270006160 | 1.52 | 51.1 | Curative (C) | 2017-03-02 | 2017-03-19 | CARBOPLATIN + RT | N | N | 270025495 | CAPECITABINE + IRINOTECAN |
| 270010491 | 270006161 | 1.8 | 69.5 | Curative (C) | 2014-12-16 | 2014-12-25 | RUXOLITINIB | 02 | N | 270025514 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010492 | 270006162 | 1.58 | 56.2 | Palliative (P) | 2014-10-05 | 2014-10-13 | Docetaxel 75mg/m2 (21 day) | N | Y | 270025521 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010493 | 270006163 | 1.63 | 76 | Neo-adjuvant (N) | 2015-11-18 | 2015-11-19 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 270025527 | RUXOLITINIB |
| 270010494 | 270006164 | 1.6 | 56.3 | Curative (C) | 2015-11-20 | 2015-11-20 | Cetuximab + Radiotherapy Load | N | N | 270025554 | CAPECITABINE + MITOMYCIN + RT |
| 270010495 | 270006165 | 1.74 | 69.4 | Palliative (P) | 2018-11-29 | 2019-01-13 | CARBOPLATIN + GEMCITABINE | N | N | 270025562 | CARBOPLATIN |
| 270010496 | 270006165 | 1.72 | 63.6 | null | 2013-03-28 | 2013-03-28 | Capecitabine (14 day) + Irinotecan | 01 | N | 270025562 | CUFOX TRIAL |
| 270010497 | 270006165 | 1.65 | null | Curative (C) | 2016-03-27 | 2016-04-05 | CISPLATIN + VINORELBINE + RT | N | N | 270025562 | CARBOPLATIN |
| 270010498 | 270006166 | 1.76 | 66.3 | Palliative (P) | 2014-07-22 | 2018-02-11 | Bevacizumab 7.5mg/kg | 2 | N | 270025577 | CETUXIMAB + RT |
| 270010499 | 270006167 | 1.89 | 72.7 | Curative (C) | 2013-12-04 | 2013-12-17 | NIVOLUMAB | N | N | 270025600 | CARBOPLATIN + RT |
| 270010500 | 270006168 | 1.87 | 90.9 | Not known (9) | 2014-06-14 | 2014-06-19 | Imatinib 400mg | N | N | 270025619 | CARBOPLATIN + RT |
| 270010501 | 270006169 | 1.72 | 71.4 | Palliative (P) | 2016-07-05 | 2016-08-09 | Cetuximab 7 day (Cycle 1) | 02 | N | 270025622 | GEMCARBO |
| 270010502 | 270013011 | null | null | Palliative (P) | 2016-06-14 | 2016-07-02 | Carboplatin AUC 2 - 5 | N | N | 270025643 | FLUOROURACIL + MITOMYCIN + RT |
| 270010503 | 270006170 | 1.7 | 114.2 | null | 2014-04-19 | 2014-04-26 | Cisplatin + Fluorouracil + RT 5day | N | N | 270025663 | CETUXIMAB |
| 270010504 | 270006170 | -1 | null | Palliative (P) | 2015-08-30 | 2015-09-08 | CARBOPLATIN | 1 | null | 270025663 | CARBOPLATIN |
| 270010505 | 270006171 | 1.62 | 45 | Curative (C) | 2016-06-08 | 2016-06-09 | Raltitrexed | N | N | 270025682 | OXALIPLATIN + RALTITREXED |
| 270010506 | 270006172 | 1.55 | 82 | Curative (C) | 2013-08-01 | 2013-08-22 | Cetuximab 14 day | N | N | 270025706 | CETUXIMAB + RT |
| 270010507 | 270006172 | 1.86 | null | Disease modification (D) | 2015-07-01 | 2015-09-05 | Fluorouracil + Folinic + RT Bossett | 02 | N | 270025706 | CETUXIMAB + RT |
| 270010508 | 270006173 | 1.93 | 59.7 | Neo-adjuvant (N) | null | 2014-04-01 | Capecitabine (21 day) + Irinotecan | 2 | N | 270025719 | CETUXIMAB + RT |
| 270010509 | 270006174 | 1.62 | null | Neo-adjuvant (N) | 2014-11-19 | 2014-11-26 | GEMCARBO | 2 | N | 270025737 | CETUXIMAB + IRINOTECAN + MDG |
| 270010510 | 270006175 | 1.76 | 0 | Curative (C) | 2017-10-19 | 2017-10-21 | CAP + RT | Y | N | 270025738 | CETUXIMAB |
| 270010511 | 270006176 | 1.69 | null | Palliative (P) | 2017-07-23 | 2017-08-07 | SCOT TRIAL | N | N | 270025740 | CETUXIMAB |
| 270010512 | 270006176 | 1.71 | 84 | Palliative (P) | 2016-01-04 | 2016-01-10 | CARBOPLATIN + RT | 2 | N | 270025740 | CETUXIMAB |